DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 72 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 248.60 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $283,000 | +26.9% | 17,952 | -1.6% | 0.00% | – |
| Q2 2018 | $223,000 | +28.2% | 18,244 | 0.0% | 0.00% | – |
| Q1 2018 | $174,000 | +5.5% | 18,244 | 0.0% | 0.00% | – |
| Q4 2017 | $165,000 | +5.1% | 18,244 | -33.3% | 0.00% | – |
| Q3 2017 | $157,000 | +53.9% | 27,342 | -14.6% | 0.00% | – |
| Q2 2017 | $102,000 | -19.0% | 32,024 | -13.4% | 0.00% | – |
| Q1 2017 | $126,000 | +18.9% | 36,978 | 0.0% | 0.00% | – |
| Q4 2016 | $106,000 | -47.5% | 36,978 | +7.9% | 0.00% | – |
| Q3 2016 | $202,000 | +96.1% | 34,273 | 0.0% | 0.00% | – |
| Q2 2016 | $103,000 | -18.9% | 34,273 | +44.9% | 0.00% | – |
| Q1 2016 | $127,000 | -15.3% | 23,657 | +87.6% | 0.00% | – |
| Q4 2015 | $150,000 | – | 12,610 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |